QQQ   325.93 (+2.79%)
AAPL   169.24 (+2.62%)
MSFT   289.16 (+2.43%)
META   178.34 (+5.82%)
GOOGL   119.70 (+2.63%)
AMZN   142.69 (+3.53%)
TSLA   883.07 (+3.89%)
NVDA   180.97 (+5.92%)
NIO   20.05 (+4.59%)
BABA   92.43 (+1.36%)
AMD   99.05 (+3.67%)
MU   61.40 (+3.80%)
T   18.01 (-0.50%)
CGC   3.29 (+14.63%)
GE   77.14 (+2.95%)
F   15.50 (+2.04%)
DIS   112.43 (+3.98%)
AMC   23.67 (+5.43%)
PYPL   98.91 (+4.69%)
PFE   49.95 (+0.34%)
NFLX   244.11 (+6.16%)
QQQ   325.93 (+2.79%)
AAPL   169.24 (+2.62%)
MSFT   289.16 (+2.43%)
META   178.34 (+5.82%)
GOOGL   119.70 (+2.63%)
AMZN   142.69 (+3.53%)
TSLA   883.07 (+3.89%)
NVDA   180.97 (+5.92%)
NIO   20.05 (+4.59%)
BABA   92.43 (+1.36%)
AMD   99.05 (+3.67%)
MU   61.40 (+3.80%)
T   18.01 (-0.50%)
CGC   3.29 (+14.63%)
GE   77.14 (+2.95%)
F   15.50 (+2.04%)
DIS   112.43 (+3.98%)
AMC   23.67 (+5.43%)
PYPL   98.91 (+4.69%)
PFE   49.95 (+0.34%)
NFLX   244.11 (+6.16%)
QQQ   325.93 (+2.79%)
AAPL   169.24 (+2.62%)
MSFT   289.16 (+2.43%)
META   178.34 (+5.82%)
GOOGL   119.70 (+2.63%)
AMZN   142.69 (+3.53%)
TSLA   883.07 (+3.89%)
NVDA   180.97 (+5.92%)
NIO   20.05 (+4.59%)
BABA   92.43 (+1.36%)
AMD   99.05 (+3.67%)
MU   61.40 (+3.80%)
T   18.01 (-0.50%)
CGC   3.29 (+14.63%)
GE   77.14 (+2.95%)
F   15.50 (+2.04%)
DIS   112.43 (+3.98%)
AMC   23.67 (+5.43%)
PYPL   98.91 (+4.69%)
PFE   49.95 (+0.34%)
NFLX   244.11 (+6.16%)
QQQ   325.93 (+2.79%)
AAPL   169.24 (+2.62%)
MSFT   289.16 (+2.43%)
META   178.34 (+5.82%)
GOOGL   119.70 (+2.63%)
AMZN   142.69 (+3.53%)
TSLA   883.07 (+3.89%)
NVDA   180.97 (+5.92%)
NIO   20.05 (+4.59%)
BABA   92.43 (+1.36%)
AMD   99.05 (+3.67%)
MU   61.40 (+3.80%)
T   18.01 (-0.50%)
CGC   3.29 (+14.63%)
GE   77.14 (+2.95%)
F   15.50 (+2.04%)
DIS   112.43 (+3.98%)
AMC   23.67 (+5.43%)
PYPL   98.91 (+4.69%)
PFE   49.95 (+0.34%)
NFLX   244.11 (+6.16%)
NYSE:ABT

Abbott Laboratories - ABT Stock Forecast, Price & News

$110.27
+2.36 (+2.19%)
(As of 08/10/2022 12:00 AM ET)
Add
Compare
Today's Range
$109.20
$110.38
50-Day Range
$102.07
$117.51
52-Week Range
$101.24
$142.60
Volume
3.95 million shs
Average Volume
5.60 million shs
Market Capitalization
$193.11 billion
P/E Ratio
23.02
Dividend Yield
1.74%
Price Target
$132.46

Abbott Laboratories MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.71 Rating Score
Upside/​Downside
20.1% Upside
$132.46 Price Target
Short Interest
Healthy
0.80% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.11
Upright™ Environmental Score
News Sentiment
0.08mentions of Abbott Laboratories in the last 14 days
Based on 29 Articles This Week
Insider Trading
Selling Shares
$5.72 M Sold Last Quarter
Proj. Earnings Growth
-7.20%
From $5.00 to $4.64 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.05 out of 5 stars

Medical Sector

31st out of 1,108 stocks

Pharmaceutical Preparations Industry

5th out of 542 stocks

ABT stock logo

About Abbott Laboratories (NYSE:ABT) Stock

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Abbott Laboratories Trading Down 1.0 %

Shares of ABT opened at $107.91 on Wednesday. The stock's 50-day moving average price is $109.00 and its 200 day moving average price is $115.44. The company has a quick ratio of 1.54, a current ratio of 2.01 and a debt-to-equity ratio of 0.46. The firm has a market capitalization of $188.97 billion, a price-to-earnings ratio of 22.53, a P/E/G ratio of 4.04 and a beta of 0.71. Abbott Laboratories has a 12-month low of $101.24 and a 12-month high of $142.60.

Abbott Laboratories (NYSE:ABT - Get Rating) last issued its earnings results on Wednesday, July 20th. The healthcare product maker reported $1.43 EPS for the quarter, beating analysts' consensus estimates of $1.09 by $0.34. Abbott Laboratories had a return on equity of 29.38% and a net margin of 18.78%. The business had revenue of $11.26 billion during the quarter, compared to analyst estimates of $10.37 billion. During the same period in the prior year, the company posted $1.17 earnings per share. Abbott Laboratories's revenue was up 10.1% on a year-over-year basis. As a group, research analysts predict that Abbott Laboratories will post 5 earnings per share for the current year.

Abbott Laboratories Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, August 15th. Stockholders of record on Friday, July 15th will be given a dividend of $0.47 per share. The ex-dividend date of this dividend is Thursday, July 14th. This represents a $1.88 annualized dividend and a dividend yield of 1.74%. Abbott Laboratories's dividend payout ratio (DPR) is currently 39.25%.

Analyst Upgrades and Downgrades

ABT has been the topic of several recent research reports. Royal Bank of Canada cut their target price on Abbott Laboratories from $143.00 to $132.00 in a report on Thursday, July 21st. Cowen cut their price objective on Abbott Laboratories from $150.00 to $130.00 in a research note on Wednesday, July 13th. BTIG Research decreased their target price on Abbott Laboratories from $130.00 to $126.00 and set a "buy" rating for the company in a research report on Monday, July 18th. Stifel Nicolaus dropped their price target on shares of Abbott Laboratories from $136.00 to $126.00 in a research report on Monday, July 18th. Finally, Wolfe Research started coverage on shares of Abbott Laboratories in a report on Tuesday, July 5th. They set an "underperform" rating for the company. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, eleven have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Abbott Laboratories presently has a consensus rating of "Moderate Buy" and a consensus price target of $132.46.

Insider Activity at Abbott Laboratories

In other Abbott Laboratories news, Director Daniel J. Starks sold 50,000 shares of Abbott Laboratories stock in a transaction that occurred on Tuesday, July 26th. The stock was sold at an average price of $109.14, for a total transaction of $5,457,000.00. Following the sale, the director now directly owns 6,923,500 shares of the company's stock, valued at $755,630,790. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, Director Daniel J. Starks sold 50,000 shares of the firm's stock in a transaction that occurred on Tuesday, July 26th. The stock was sold at an average price of $109.14, for a total transaction of $5,457,000.00. Following the completion of the transaction, the director now owns 6,923,500 shares in the company, valued at approximately $755,630,790. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Fernando Mateus sold 2,457 shares of the company's stock in a transaction on Tuesday, July 26th. The shares were sold at an average price of $109.05, for a total value of $267,935.85. Following the completion of the sale, the senior vice president now owns 14,503 shares in the company, valued at $1,581,552.15. The disclosure for this sale can be found here. 0.52% of the stock is currently owned by insiders.

Receive ABT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abbott Laboratories and its competitors with MarketBeat's FREE daily newsletter.

ABT Stock News Headlines

Use These To Find Your Stock’s Support and Resistance Levels (ABT)
A stock is a trading and investing instrument representative of an underlying business but surprisingly gets too often misunderstood in a bear market.
How to Buy Abbott Laboratories Dividend Stock 
Average 126% gains – NO losers!?  
An epic crash is all but inevitable, but these dark times can offer staggering opportunities. Today, Dr. Martin Weiss reveals "Crash Profit Trades" that could have produced average gains of 126% even when stocks tumbled. All with NO losing trades! Click Here to Discover the Secret. pixel
Medtronic Stock Keeps Ticking Forward (ABT)
Medical device maker Medtronic (NYSE: MDT) stock is trading down (-14%) for the year.
Abbott Labs Stock Can Be a Recession Hedge for Your Portfolio
Diversified global medical science products maker Abbott (NYSE: ABT) stock is down a modest (-11.5%) on the year. Abbott provides full lifecycle health and medical products from baby formula to nutrition supplement products, chronic disease treatments and medical devices to generic pharmaceuticals
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%! When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate. pixel
Abbott Laboratories: A Lesser Johnson & Johnson?
See More Headlines
Receive ABT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abbott Laboratories and its competitors with MarketBeat's FREE daily newsletter.

ABT Company Calendar

Ex-Dividend for 5/16 Dividend
4/13/2022
Dividend Payable
5/16/2022
Ex-Dividend for 8/15 Dividend
7/14/2022
Last Earnings
7/20/2022
Today
8/10/2022
Dividend Payable
8/15/2022
Next Earnings (Estimated)
10/19/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
00282410
CIK
1800
Employees
113,000
Year Founded
1888

Price Target and Rating

Average Stock Price Forecast
$132.46
High Stock Price Forecast
$150.00
Low Stock Price Forecast
$112.00
Forecasted Upside/Downside
+20.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.71
Research Coverage
14 Analysts

Profitability

Net Income
$7.07 billion
Pretax Margin
22.06%

Debt

Sales & Book Value

Annual Sales
$43.08 billion
Cash Flow
$7.37 per share
Book Value
$20.37 per share

Miscellaneous

Outstanding Shares
1,751,220,000
Free Float
1,742,114,000
Market Cap
$193.11 billion
Optionable
Optionable
Beta
0.71

Social Links















ABT Stock - Frequently Asked Questions

Should I buy or sell Abbott Laboratories stock right now?

14 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Abbott Laboratories in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ABT shares.
View ABT analyst ratings
or view top-rated stocks.

What is Abbott Laboratories' stock price forecast for 2022?

14 equities research analysts have issued 12-month price objectives for Abbott Laboratories' stock. Their ABT share price forecasts range from $112.00 to $150.00. On average, they expect the company's stock price to reach $132.46 in the next year. This suggests a possible upside of 20.5% from the stock's current price.
View analysts price targets for ABT
or view top-rated stocks among Wall Street analysts.

How have ABT shares performed in 2022?

Abbott Laboratories' stock was trading at $140.74 at the beginning of 2022. Since then, ABT stock has decreased by 21.9% and is now trading at $109.90.
View the best growth stocks for 2022 here
.

When is Abbott Laboratories' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, October 19th 2022.
View our ABT earnings forecast
.

How were Abbott Laboratories' earnings last quarter?

Abbott Laboratories (NYSE:ABT) announced its quarterly earnings data on Wednesday, July, 20th. The healthcare product maker reported $1.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.09 by $0.34. The healthcare product maker earned $11.26 billion during the quarter, compared to analyst estimates of $10.37 billion. Abbott Laboratories had a trailing twelve-month return on equity of 29.38% and a net margin of 18.78%. The company's revenue was up 10.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.17 earnings per share.
Read the conference call transcript
.

How often does Abbott Laboratories pay dividends? What is the dividend yield for Abbott Laboratories?

Abbott Laboratories declared a quarterly dividend on Friday, June 10th. Stockholders of record on Friday, July 15th will be paid a dividend of $0.47 per share on Monday, August 15th. This represents a $1.88 annualized dividend and a yield of 1.71%. The ex-dividend date is Thursday, July 14th.
Read our dividend analysis for ABT
.

Is Abbott Laboratories a good dividend stock?

Abbott Laboratories (NYSE:ABT) pays an annual dividend of $1.88 per share and currently has a dividend yield of 1.72%. The company has been increasing its dividend for 50 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 39.25%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ABT will have a dividend payout ratio of 40.52% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ABT.

How will Abbott Laboratories' stock buyback program work?

Abbott Laboratories announced that its Board of Directors has authorized a stock buyback program on Friday, December 10th 2021, which permits the company to buyback $5,000,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to repurchase up to 2.1% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's board of directors believes its stock is undervalued.

What guidance has Abbott Laboratories issued on next quarter's earnings?

Abbott Laboratories updated its FY 2022 earnings guidance on Wednesday, August, 3rd. The company provided EPS guidance of $4.90- for the period, compared to the consensus EPS estimate of $4.88. The company issued revenue guidance of -.

What is Robert Ford's approval rating as Abbott Laboratories' CEO?

183 employees have rated Abbott Laboratories Chief Executive Officer Robert Ford on Glassdoor.com. Robert Ford has an approval rating of 89% among the company's employees.

What other stocks do shareholders of Abbott Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Abbott Laboratories investors own include AbbVie (ABBV), Johnson & Johnson (JNJ), NVIDIA (NVDA), AT&T (T), Pfizer (PFE), Walt Disney (DIS), Cisco Systems (CSCO), Intel (INTC), Home Depot (HD) and Verizon Communications (VZ).

What is Abbott Laboratories' stock symbol?

Abbott Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABT."

Who are Abbott Laboratories' major shareholders?

Abbott Laboratories' stock is owned by a variety of retail and institutional investors. Top institutional investors include Jennison Associates LLC (0.62%), Swiss National Bank (0.44%), Sumitomo Mitsui Trust Holdings Inc. (0.33%), CIBC Private Wealth Group LLC (0.25%), TD Asset Management Inc. (0.22%) and US Bancorp DE (0.17%). Insiders that own company stock include Andrea F Wainer, Andrew H Lane, Brian B Yoor, Christopher J Scoggins, Daniel Gesua Sive Salvadori, Daniel J Starks, Fernando Mateus, Jared Watkin, John F Ginascol, Joseph J Manning, Julie L Tyler, Lisa D Earnhardt, Louis H Morrone, Mary K Moreland, Michael D Dale, Michael J Pederson, Michelle Kumbier, Nancy Mckinstry, Phebe N Novakovic, Philip P Boudreau, Randel William Woodgrift, Robert E Funck, Roger Bird, Roxanne S Austin and Sammy Karam.
View institutional ownership trends
.

How do I buy shares of Abbott Laboratories?

Shares of ABT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Abbott Laboratories' stock price today?

One share of ABT stock can currently be purchased for approximately $109.90.

How much money does Abbott Laboratories make?

Abbott Laboratories (NYSE:ABT) has a market capitalization of $192.46 billion and generates $43.08 billion in revenue each year. The healthcare product maker earns $7.07 billion in net income (profit) each year or $4.79 on an earnings per share basis.

How many employees does Abbott Laboratories have?

The company employs 113,000 workers across the globe.

Does Abbott Laboratories have any subsidiaries?

The following companies are subsidiares of Abbott Laboratories: 3A Nutrition (Vietnam) Company Limited, ABON Biopharm (Hangzhou) Co. Ltd., AGA Medical Belgium, AGA Medical Corporation, AGA Medical Holdings Inc., ALR Holdings, AML Medical LLC, APK Advanced Medical Technologies LLC, ATS Bermuda Holdings Limited, ATS Laboratories Inc., Abbott, Abbott (Jiaxing) Nutrition Co. Ltd., Abbott (UK) Finance Limited, Abbott (UK) Holdings Limited, Abbott AG, Abbott Asia Holdings Limited, Abbott Asia Investments Limited, Abbott Australasia Holdings Limited, Abbott Australasia Pty Ltd, Abbott B.V., Abbott Bahamas Overseas Businesses Corporation, Abbott Belgian Investments, Abbott Bermuda Holding Ltd., Abbott Biologicals B.V., Abbott Biologicals LLC, Abbott Bulgaria Luxembourg S.à r.l., Abbott Capital India Limited, Abbott Cardiovascular Inc., Abbott Cardiovascular Systems Inc., Abbott Delaware LLC, Abbott Diabetes Care Inc., Abbott Diabetes Care Limited, Abbott Diabetes Care Sales Corporation, Abbott Diagnostics GmbH, Abbott Diagnostics International Ltd., Abbott Diagnostics Technologies AS, Abbott Doral Investments S.L., Abbott Equity Holdings Unlimited, Abbott Equity Investments LLC, Abbott Established Products Holdings (Gibraltar) Limited, Abbott Finance Company SA, Abbott Financial Holdings SRL, Abbott France S.A.S., Abbott Fund Tanzania Limited, Abbott Gesellschaft m.b.H., Abbott GmbH & Co. KG, Abbott Health Products LLC, Abbott Healthcare (Puerto Rico) Ltd., Abbott Healthcare B.V., Abbott Healthcare Costa Rica S.A., Abbott Healthcare LLC, Abbott Healthcare Luxembourg S.à r.l., Abbott Healthcare Private Limited, Abbott Healthcare Products B.V., Abbott Healthcare Products Ltd, Abbott Holding (Gibraltar) Limited, Abbott Holding GmbH, Abbott Holding Subsidiary (Gibraltar) Limited, Abbott Holding Subsidiary (Gibraltar) Limited Luxembourg S.C.S., Abbott Holdings B.V., Abbott Holdings LLC, Abbott Holdings Limited, Abbott Holdings Poland Spółka z ograniczoną odpowiedzialnością, Abbott Hungary Korlátolt Felelősségű Társaság, Abbott Iberian Investments (2) Limited, Abbott Iberian Investments Limited, Abbott India Limited, Abbott Informatics Asia Pacific Limited, Abbott Informatics Canada Inc, Abbott Informatics Corporation, Abbott Informatics Europe Limited, Abbott Informatics France, Abbott Informatics Germany GmbH, Abbott Informatics Netherlands B.V., Abbott Informatics Singapore Pte. Limited, Abbott Informatics Spain S.A., Abbott Informatics Technologies Ltd, Abbott International Corporation, Abbott International Enterprises Ltd., Abbott International Holdings Limited, Abbott International LLC, Abbott International Luxembourg S.àr.l., Abbott Investments Luxembourg S.à r.l., Abbott Ireland, Abbott Ireland Financing Designated Activity Company, Abbott Ireland Limited, Abbott Japan Co. Ltd., Abbott Kazakhstan Limited Liability Partnership, Abbott Knoll Investments B.V., Abbott Korea Limited, Abbott Laboratories (Bangladesh) Limited, Abbott Laboratories (Chile) Holdco (Dos) SpA, Abbott Laboratories (Chile) Holdco SpA, Abbott Laboratories (Malaysia) Sdn. Bhd., Abbott Laboratories (Mozambique) Limitada, Abbott Laboratories (Pakistan) Limited, Abbott Laboratories (Philippines), Abbott Laboratories (Puerto Rico) Incorporated, Abbott Laboratories (Singapore) Private Limited, Abbott Laboratories A/S, Abbott Laboratories Argentina Sociedad Anónima, Abbott Laboratories B.V., Abbott Laboratories C.A., Abbott Laboratories Finance B.V., Abbott Laboratories GmbH, Abbott Laboratories Inc., Abbott Laboratories International LLC, Abbott Laboratories Ireland Limited, Abbott Laboratories Limited, Abbott Laboratories Limited - Laboratoires Abbott Limitée, Abbott Laboratories NZ Limited, Abbott Laboratories Pacific Ltd., Abbott Laboratories Poland Spółka z ograniczoną odpowiedzialnością, Abbott Laboratories Products B.V., Abbott Laboratories Residential Development Fund Inc., Abbott Laboratories S.A., Abbott Laboratories SA, Abbott Laboratories Services Corp., Abbott Laboratories Slovakia s.r.o., Abbott Laboratories South Africa (Pty) Ltd., Abbott Laboratories Trading (Shanghai) Co. Ltd., Abbott Laboratories Trustee Company Limited, Abbott Laboratories Uruguay S.A., Abbott Laboratories Vascular Enterprises, Abbott Laboratories d.o.o., Abbott Laboratories de Chile Limitada, Abbott Laboratories de Colombia S.A., Abbott Laboratories de México S.A. de C.V., Abbott Laboratories družba za farmacijo in diagnostiko d.o.o., Abbott Laboratories s.r.o., Abbott Laboratories(Hellas) Societe Anonyme, Abbott Laboratorios S.A., Abbott Laboratorios S.A., Abbott Laboratorios del Ecuador Cia. Ltda., Abbott Laboratuarlari Ithalat Ihracat ve Ticaret Ltd.Sti, Abbott Laboratórios Lda, Abbott Laboratórios do Brasil Ltda., Abbott Limited Egypt LLC, Abbott Logistics B.V., Abbott Management GmbH, Abbott Management LLC, Abbott Manufacturing Singapore Private Limited, Abbott Mature Products International Unlimited Company, Abbott Mature Products Management Limited, Abbott Medical (Hong Kong) Limited, Abbott Medical (Malaysia) Sdn. Bhd., Abbott Medical (Portugal) Distribuicao de Produtos Medicos Lda, Abbott Medical (Schweiz) AG, Abbott Medical (Shanghai) Co. Ltd., Abbott Medical (Singapore) Pte. Ltd., Abbott Medical (Thailand) Co. Ltd., Abbott Medical Australia Pty. Ltd., Abbott Medical Austria Ges.m.b.H., Abbott Medical Balkan d.o.o. Beograd (Novi Beograd), Abbott Medical Belgium, Abbott Medical Canada Inc./ Médicale Abbott Canada Inc., Abbott Medical Danmark A/S, Abbott Medical Devices Trading (Shanghai) Co. Ltd., Abbott Medical España S.A., Abbott Medical Estonia OÜ, Abbott Medical Finland Oy, Abbott Medical France SAS, Abbott Medical GmbH, Abbott Medical Hellas Limited Liability Trading Company, Abbott Medical Ireland Limited, Abbott Medical Italia S.p.A., Abbott Medical Japan Co. Ltd., Abbott Medical Korea Limited, Abbott Medical Korlátolt Felelősségű Társaság, Abbott Medical Laboratories LTD, Abbott Medical Nederland B.V., Abbott Medical New Zealand Limited, Abbott Medical Norway AS, Abbott Medical Overseas Cyprus Limited, Abbott Medical Sweden AB, Abbott Medical Taiwan Co., Abbott Medical U.K. Limited, Abbott Medical spółka z ograniczoną odpowiedzialnością, Abbott Middle East S.A.R.L., Abbott Molecular Inc., Abbott Morocco SARL, Abbott Nederland C.V., Abbott Nederland Luxembourg S.à r.l., Abbott Netherlands Investments B.V., Abbott Norge AS, Abbott Nutrition Limited, Abbott Nutrition Manufacturing Inc., Abbott Operations Singapore Pte. Ltd., Abbott Operations Uruguay S.R.L., Abbott Overseas Cyprus Limited, Abbott Overseas Luxembourg S.à r.l., Abbott Overseas S.A., Abbott Oy, Abbott Point of Care Canada Limited, Abbott Point of Care Inc., Abbott Poland Luxembourg S.à r.l., Abbott Procurement LLC, Abbott Products (Philippines) Inc., Abbott Products (Spain) S.L., Abbott Products Algerie EURL, Abbott Products B.V., Abbott Products Distribution SAS, Abbott Products Egypt LLC, Abbott Products Limited, Abbott Products Limited Liability Company, Abbott Products Luxembourg S.à r.l., Abbott Products Operations AG, Abbott Products Operations LLC, Abbott Products Romania S.R.L., Abbott Products Tunisie S.A.R.L., Abbott Products Unlimited Company, Abbott Resources Inc., Abbott Resources International Inc., Abbott S.r.l., Abbott Saudi Arabia Trading Company, Abbott Scandinavia Aktiebolag, Abbott Sociedad Anonima de Capital Variable, Abbott South Africa Luxembourg S.à r.l., Abbott Strategic Opportunities Limited, Abbott Trading Company Inc., Abbott Universal LLC, Abbott Vascular Devices (2) Limited, Abbott Vascular Devices Limited, Abbott Vascular Inc., Abbott Vascular Instruments Deutschland GmbH, Abbott Vascular International, Abbott Vascular Japan Co. Ltd, Abbott Vascular Limitada, Abbott Vascular Netherlands B.V., Abbott Vascular Solutions Inc., Abbott Ventures Inc., Abbott West Indies Limited, Abbott društvo sa ogranicenom odgovornošcu za trgovinu i usluge, Advanced Neuromodulation Systems Inc., Alere, Alere (Shanghai) Diagnostics Co. Ltd., Alere (Shanghai) Healthcare Management Co. Ltd., Alere (Shanghai) Medical Sales Co. Ltd., Alere (Shanghai) Technology Co. Ltd., Alere A/S, Alere AB, Alere AS, Alere AS Holdings Limited, Alere BBI Holdings Limited, Alere Bangladesh Limited, Alere China Co. Ltd., Alere Colombia S.A., Alere Connect LLC, Alere Connected Health Limited, Alere Connected Health Ltd., Alere Diagnostics GmbH, Alere DoA Holding GmbH, Alere GmbH, Alere GmbH (Austria), Alere GmbH (Germany), Alere HK Holdings Ltd., Alere Health B.V., Alere Health BVBA, Alere Health Corp., Alere Health Sdn Bhd, Alere Health Services B.V., Alere Healthcare (Pty) Limited, Alere Healthcare Connections Limited, Alere Healthcare Inc., Alere Healthcare Nigeria Limited, Alere Healthcare S.L., Alere Holdco Inc., Alere Holding GmbH, Alere Holdings Bermuda Limited, Alere Holdings Pty Limited, Alere Home Monitoring Inc., Alere Inc., Alere Informatics Inc., Alere International Holding Corp., Alere International Limited, Alere Lda, Alere Limited, Alere Limited (New Zealand), Alere Medical BVBA, Alere Medical Co. Ltd., Alere Medical Pakistan (Private) Limited, Alere Medical Private Limited, Alere North America LLC, Alere Oy Ab, Alere Philippines Inc., Alere Phoenix ACQ Inc., Alere Pte Ltd, Alere S.A., Alere S.r.l., Alere S/A, Alere SAS, Alere San Diego Inc., Alere Scarborough Inc., Alere Spain S.L., Alere Switzerland GmbH, Alere Technologies GmbH, Alere Technologies Holdings Limited, Alere Technologies Limited, Alere Toxicology AB, Alere Toxicology Inc., Alere Toxicology S.r.l., Alere Toxicology Services Inc., Alere Toxicology plc, Alere UK Holdings Limited, Alere UK Subco Limited, Alere ULC, Alere US Holdings LLC, Alere s.r.o., Alisoc Investment & Co, Amedica Biotech Inc., Ameditech Inc., American Generics S.A.S., American Medical Supplies Inc., American Pharmacist Inc., Antares S.A., Apica Cardiovascular Limited, Aquagestion Capacitación S.A., Aquagestion S.A., Arriva Medical LLC, Arriva Medical Philippines Inc., Arvis Investments Limited, Atlas Farmacéutica S.A., Avee Laboratories Inc., Axis-Shield AD III AS, Axis-Shield AD IV AS, Axis-Shield AS, Axis-Shield Diagnostics Limited, Axis-Shield Ltd., BBI Animal Health Limited, BBI Diagnostics Group 2 Public Limited Company, Banco de Vida S.A., Bioabsorbable Vascular Solutions Inc., Bioalgae S.A., Biohealth LLC, Biosite Incorporated, Bosque Bonito S.A., Branan Medical Corporation, Brandex Europe C.V., British Colloids Limited, CFR Chile S.A., CFR Interamericas EL Salvador Sociedad Anónima de Capital Variable, CFR Interamericas Nicaragua Sociedad Anónima, CFR Interamericas Panamá S.A., CFR Pharmaceuticals, California Property Holdings III LLC, CardioMEMS LLC, Caripharm Inc., Cephea Valve Technologies, Cephea Valve Technologies Inc., Colibri Medical Aktiebolag, Comercializadora y Distribuidora CFR Interamericas Honduras S.A., Concateno South Limited, Concateno UK Limited, Consorcio Tecnológico en Biomedicina Clinico-Molecular S.A., Continuum Services LLC, Cozart Limited, Dextech S.A., Diagnostik Nord GmbH, Distribuciones Uquifa S.A.S., Domesco Medical Import-Export Joint-Stock Corporation, Duphar International Research B.V., Endocardial Solutions, Epocal (US) Inc, Esprit de Vie S.A., European Chemicals & Co, European Drug Testing Service EDTS AB, European Services S.A., Evalve Inc., Evalve International Inc., FARMINDUSTRIA S.A., Fada Pharma Paraguay Sociedad Anonima, Fadapharma del Ecuador S.A., Farmaceutica Mont Blanc S.L., Farmacologia Em Aquicultura Veterinária Ltda., Farmacologia en Aquacultura Veterinaria FAV Ecuador S.A., Farmacología en Aquacultura Veterinaria FAV S.A., Fernwood Investment S.A., First Check Diagnostics LLC, Focus Pharmaceutical S.A.S., Forensics Limited, Forestcreek Overseas S.A., Fournier Pharma Corp., Fournier Pharma GmbH, Fournier Pharmaceuticals Limited, Framed B.V., Gabmed GmbH, Garden Hills LLC, Global Analytical Development LLC, Globapharm & CO LP, Glomed Pharmaceutical Company Limited, Golnorth Investments S.A., Gynocare Limited, Gynopharm Sociedad Anonima, Gynopharm de Centroamérica S.A., Gynopharm de Venezuela C.A., Hi-Tronics Designs Inc., IDEV Technologies Inc., IG Innovations Limited, IMTC Finance B.V., IMTC Holdings B.V., IMTC Technologies Inc., Ibis Biosciences LLC, Igloo Zone Chile S.A., Igloo Zone S.L., Inmobiliaria Naknek S.A.C., Innovacon Inc., Instant Tech Subsidiary Acquisition Inc., Instant Technologies Inc., Instituto de Criopreservación de Chile S.A., Integrated Vascular Systems Inc., Inverness Canadian Acquisition Corporation, Inverness Medical (Beijing) Co. Ltd., Inverness Medical Innovations Australia Pty Ltd., Inverness Medical Innovations Hong Kong Limited, Inverness Medical Innovations SK LLC, Inverness Medical Investments LLC, Inverness Medical LLC, Inverness Medical Shimla Private Limited, Inversiones K2 SpA, Inversiones Komodo S.R.L., Ionian Technologies LLC, Irvine Biomedical Inc., Kalila Medical, Kangshenyunga S.A., Knoll UK Investments Unlimited, LLC “VeroInPharm”, Laboratoires Fournier S.A.S., Laboratorio Franco Colombiano Lafrancol S.A.S., Laboratorio Franco Colombiano del Ecuador S.A., Laboratorio Internacional Argentino S.A., Laboratorio Synthesis S.A.S., Laboratorios Lafi Limitada, Laboratorios Naturmedik S.A.S., Laboratorios Pauly Pharmaceutical S.A.S., Laboratorios Recalcine S.A., Laboratorios Transpharm S.A., Laboratory Specialists of America Inc., Lafrancol Dominicana S.A.S., Lafrancol Guatemala S.A. Sociedad Anónima, Lafrancol Internacional S.A.S, Lafrancol Perú S.R.L, Lake Forest Investments LLC, Lightlab Imaging Inc., Limited Liability Company Abbott Laboratories, Limited Liability Company “Abbott Ukraine”, Limited Liability Company “VEROPHARM”, Lung Fung Hong (China) Limited, Mansbridge Pharmaceuticals Limited, MediGuide LLC, MediGuide Ltd., Medscreen Holdings Limited, Metropolitana Farmacéutica S.A., Midwest Properties LLC, Murex Argentina S.A., Murex Biotech Limited, Murex Biotech South Africa, Murex Diagnostics Inc., Murex Diagnostics International Inc., Natural Supplement Association LLC, Negocios Denia Sociedad Anónima, Neosalud S.A.C., Nether Pharma N.P. C.V., NeuroTherm LLC, Normann Pharma-Handels GmbH, North Shore Properties Inc., Novamedi S.A., Novasalud.com S.A., Nutravida S.A., OJSC “Voronezhkhimpharm”, Omnilab Iberia Sociedad Limitada, OptiMedica, Orgenics France SAS, Orgenics International Holdings B.V., Orgenics Ltd., PBM-Selfcare LLC, PDD II LLC, PDD LLC, PT Alere Health, PT. Abbott Indonesia, PT. Abbott Products Indonesia, Pacesetter Inc., Pantech (RF) (PTY) LTD, Pembrooke Occupational Health Inc., Penagos S.A., Pharma International Sociedad Anonima, Pharmaceutical Technologies (Pharmatech) S.A., Pharmatech Boliviana S.A., Polygon Labs S.A., Quality Assured Services Inc., RF Medical Holdings LLC, RTL Holdings Inc., Ramses Business Corp., Recben Xenerics Farmaceutica Limitada, Redwood Toxicology Laboratory Inc., Rich Horizons International Limited, SC “VEROPHARM”, SJ Medical Mexico S de R.L. de C.V., SJM International Inc., SJM Thunder Holding Company, SPDH Inc., Saboya Enterprises Corporation, Salviac Limited, Scanax AS, Sealing Solutions Inc., Selfcare Technology Inc., Shandong Abbott Dairy Product Co. Ltd., Shanghai Abbott Medical Devices Science and Technology Co. Ltd., Shanghai Abbott Pharmaceutical Co. Ltd., Shanghai Si Fa Pharmaceutical Company Limited, Sinensix & Co., Spinal Modulation LLC, St. Jude Medical, St. Jude Medical AB, St. Jude Medical ATG Inc., St. Jude Medical Argentina S.A., St. Jude Medical Asia Pacific Holdings GK, St. Jude Medical Atrial Fibrillation Division Inc., St. Jude Medical Brasil Ltda., St. Jude Medical Business Services Inc., St. Jude Medical Cardiology Division Inc., St. Jude Medical Colombia Ltda., St. Jude Medical Coordination Center, St. Jude Medical Costa Rica Limitada, St. Jude Medical Europe Inc., St. Jude Medical Export Ges.m.b.H., St. Jude Medical GVA Sàrl, St. Jude Medical Holdings B.V., St. Jude Medical India Private Limited, St. Jude Medical International Holding, St. Jude Medical LLC, St. Jude Medical Luxembourg, St. Jude Medical Luxembourg Holdings II, St. Jude Medical Luxembourg Holdings NT, St. Jude Medical Luxembourg Holdings SMI S.à r.l., St. Jude Medical Luxembourg Holdings TC S.à r.l., St. Jude Medical Mexico Business Services S. de R.L. de C.V., St. Jude Medical Middle East DMCC, St. Jude Medical Operations (Malaysia) Sdn. Bhd., St. Jude Medical Puerto Rico LLC, St. Jude Medical S.C. Inc., St. Jude Medical Systems AB, St. Jude Medical Turkey Medikal Ürünler Ticaret Limited Sirketi, Standard Diagnostics Inc., Standing Stone LLC, Swan-Myers Incorporated, TC1 LLC, Tendyne Holdings Inc., Tendyne Medical Inc., Thoratec Delaware LLC, Thoratec Europe Limited, Thoratec LLC, Thoratec Switzerland GmbH, Tobal Products Incorporated, Topera GmbH in Liquidation, Topera Inc., Tremora S.A., Tuenir S.A., TwistDx, UAB “Abbott Laboratories”, UAB “Abbott Medical Lithuania”, Union-Madison Realty Company Inc., Unipath Limited (dba Alere International/aka Cranfield), Unipath Management Limited, Unipath Pension Trustee Limited, Veropharm, Veropharm Limited Liability Partnership, Vida Cell Inversiones S.A., Vida Cell S.A., Vivalsol, W&R Pharma Handels GmbH, Western Pharmaceuticals S.A., X Technologies Inc., Yissum Holding Limited, ZonePerfect Nutrition Company, eScreen Canada ULC, eScreen Inc., Товариство з обмеженою відповідальністю «Верофарм» (ТОВ «Верофарм»), and “Abbott Laboratories Baltics”.
Read More

When was Abbott Laboratories founded?

Abbott Laboratories was founded in 1888.

How can I contact Abbott Laboratories?

Abbott Laboratories' mailing address is 100 ABBOTT PARK ROAD D-322 AP6D, ABBOTT PARK IL, 60064. The official website for the company is www.abbott.com. The healthcare product maker can be reached via phone at (224) 667-6100 or via fax at 847-937-1511.

This page (NYSE:ABT) was last updated on 8/10/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.